Nadezhda Anikeyeva, PhD

Contact Dr. Anikeyeva

233 South Tenth Street
Bluemle Life Sciences Building, Room 706
Philadelphia, PA 19107

(215) 503-4532
(215) 503-7566 fax

Most Recent Peer-reviewed Publications

  1. Limited immune surveillance in lymphoid tissue by cytolytic CD4+ T cells during health and HIV disease
  2. Evaluating frequency and quality of pathogen-specific T cells
  3. Integrins influence the size and dynamics of signaling microclusters in a Pyk2-dependent manner
  4. Core-based lipid nanoparticles as a nanoplatform for delivery of near-infrared fluorescent imaging agents
  5. Integrin receptors on tumor cells facilitate NK cell-mediated antibody-dependent cytotoxicity
  6. Evidence that the density of self peptide-MHC ligands regulates T-cell receptor signaling
  7. Mechanisms controlling granule-mediated cytolytic activity of cytotoxic T lymphocytes
  8. Quantum dots as a unique nanoscaffold to mimic membrane receptor clustering
  9. Kinetics of Early T Cell Receptor Signaling Regulate the Pathway of Lytic Granule Delivery to the Secretory Domain
  10. Can oligomeric T-cell receptor be used as a tool to detect viral peptide epitopes on infected cells?
  11. Protein kinase Cθ regulates stability of the peripheral adhesion ring junction and contributes to the sensitivity of target cell lysis by CTL
  12. Quantum dot/peptide-MHC biosensors reveal strong CD8-dependent cooperation between self and viral antigens that augment the T cell response
  13. Structural basis for degenerate recognition of natural HIV peptide variants by cytotoxic lymphocytes
  14. Antagonism of HIV-specific CD4+ T cells by C-terminal truncation of a minimum epitope
  15. Distinct role of lymphocyte function-associated antigen-1 in mediating effective cytolytic activity by cytotoxic T lymphocytes
  16. Production of soluble form of human TNF-alpha ligand-binding domain type 1 receptor by expression in Drosophila cells
  17. Major histocompatibility complex class I-intercellular adhesion molecule-1 association on the surface of target cells: Implications for antigen presentation to cytotoxic T lymphocytes
  18. Antibody specific for the peptide·major histocompatibility complex: Is it T cell receptor-like?
  19. Cytotoxic T lymphocytes form an antigen-independent ring junction
  20. Cytotoxic T lymphocytes form an antigen-independent ring junction.